Impact of Tumor Progression on Cancer Incidence Curves
- 31 January 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 73 (3), 1086-1096
- https://doi.org/10.1158/0008-5472.can-12-2198
Abstract
Cancer arises through a multistage process, but it is not fully clear how this process influences the age-specific incidence curve. Studies of colorectal and pancreatic cancer using the multistage clonal expansion (MSCE) model have identified two phases of the incidence curves. One phase is linear, beginning about age of 60 years, suggesting that at least two rare rate-limiting mutations occur before clonal expansion of premalignant cells. A second phase is exponential, seen in early-onset cancers occurring before the age of 60 years that are associated with premalignant clonal expansion. Here, we extend the MSCE model to include clonal expansion of malignant cells, an advance that permits study of the effects of tumor growth and extinction on the incidence of colorectal, gastric, pancreatic, and esophageal adenocarcinomas in the digestive tract. After adjusting the age-specific incidence for birth-cohort and calendar-year trends, we found that initiating mutations and premalignant cell kinetics can explain the primary features of the incidence curve. However, we also found that the incidence data of these cancers harbored information on the kinetics of malignant clonal expansion before clinical detection, including tumor growth rates and extinction probabilities on three characteristic time scales for tumor progression. In addition, the data harbored information on the mean sojourn times for premalignant clones until occurrence of either the first malignant cell or the first persistent (surviving) malignant clone. Finally, the data also harbored information on the mean sojourn time of persistent malignant clones to the time of diagnosis. In conclusion, cancer incidence curves can harbor significant information about hidden processes of tumor initiation, premalignant clonal expansion, and malignant transformation, and even some limited information on tumor growth before clinical detection. Cancer Res; 73(3); 1086–96. ©2012 AACR.Keywords
Other Versions
This publication has 48 references indexed in Scilit:
- A new branch on the tree: Next-generation sequencing in the study of cancer evolutionSeminars in Cell & Developmental Biology, 2012
- Spatial structure increases the waiting time for cancerNew Journal of Physics, 2011
- Establishment and Characterization of a New Cell Line, A99, From a Primary Small Cell Carcinoma of the PancreasPancreas, 2011
- Colorectal Cancer Incidence Trends in the United States and United Kingdom: Evidence of Right- to Left-Sided Biological Gradients with Implications for ScreeningCancer Research, 2010
- Modeling progression in radiation-induced lung adenocarcinomasRadiation and Environmental Biophysics, 2010
- Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancerProceedings of the National Academy of Sciences of the United States of America, 2010
- Age-specific incidence of cancer: Phases, transitions, and biological implicationsProceedings of the National Academy of Sciences of the United States of America, 2008
- Comparative lesion sequencing provides insights into tumor evolutionProceedings of the National Academy of Sciences of the United States of America, 2008
- Genetic Progression and the Waiting Time to CancerPLoS Computational Biology, 2007
- APC mutations occur early during colorectal tumorigenesisNature, 1992